Lv42
584 积分 2022-03-28 加入
Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis
4小时前
待确认
Clinical application of base editing for treating β-thalassaemia
7小时前
待确认
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
1天前
待确认
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
1天前
待确认
In vivo chimeric antigen receptor (CAR)-T cell therapy
1天前
待确认
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
9天前
已完结
CAR-T cells in the treatment of neurological autoimmune diseases
10天前
已完结
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies
18天前
已完结
CAR-T cells in the treatment of neurological autoimmune diseases
22天前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
2个月前
已完结
皖公网安备34019202002308
